Your browser doesn't support javascript.
loading
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.
Landells, Ian; Marano, Colleen; Hsu, Ming-Chun; Li, Shu; Zhu, Yaowei; Eichenfield, Lawrence F; Hoeger, Peter H; Menter, Alan; Paller, Amy S; Taieb, Alain; Philipp, Sandra; Szapary, Philippe; Randazzo, Bruce.
Afiliación
  • Landells I; Memorial University of Newfoundland, St. Johns, Newfoundland, Canada. Electronic address: landells@nexusresearch.com.
  • Marano C; Janssen Research & Development, LLC., Spring House, Pennsylvania.
  • Hsu MC; Janssen Research & Development, LLC., Spring House, Pennsylvania.
  • Li S; Janssen Research & Development, LLC., Spring House, Pennsylvania.
  • Zhu Y; Janssen Research & Development, LLC., Spring House, Pennsylvania.
  • Eichenfield LF; University of California, San Diego, California.
  • Hoeger PH; University of Hamburg and Catholic Children's Hospital, Hamburg, Germany.
  • Menter A; Baylor University Medical Center and Texas A&M Health Science Center School of Medicine, Dallas, Texas.
  • Paller AS; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Taieb A; Bordeaux University Hospitals, University of Bordeaux, Bordeaux, France.
  • Philipp S; Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Germany.
  • Szapary P; Janssen Research & Development, LLC., Spring House, Pennsylvania.
  • Randazzo B; Janssen Research & Development, LLC., Spring House, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
J Am Acad Dermatol ; 73(4): 594-603, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26259989

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Ustekinumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Ustekinumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Año: 2015 Tipo del documento: Article
...